Akebia Therapeutics, Inc. (AKBA) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	90.5	149.8	228.7	147.4	104.6	70.2	187.3	49.8
Short-term investments							73.0	88.7
Accounts receivable, net	39.2	50.9	26.9	38.9	16.7	34.2	33.8
Inventories	21.8	38.2	61.0	116.3	114.2
Other current assets	33.5	33.1	54.9	6.9	232.7	254.0	2.2	2.6
Total current assets	184.9	272.0	371.4	309.5	468.3	358.4	296.3	141.0
Property, plant, and equipment, net	5.2	6.8	8.6	10.4	8.0	3.6	2.6	0.5
Goodwill	55.1	55.1	55.1	55.1	55.1
Other fixed assets	5.4	49.8	38.0	76.0	137.0	2.3	1.3	1.3
Total assets	351.8	525.6	644.1	771.2	996.5	364.2	300.2	142.9

Accounts payable	18.0	33.6	41.3	39.2	42.8	7.0	2.0	2.3
Accrued expenses	71.0	104.5	130.6	129.1	150.9	52.4	30.3	9.6
Current portion of long-term debt	32.0	97.5	0.0	0.0	15.0	0.0	0.0	0.0
Current portion of long-term debt	32.0	97.5			15.0
Deferred revenues	3.7						82.0
Other current liabilities		20.9	15.2	39.8	57.0	81.7
Total current liabilities	124.8	256.5	187.1	208.1	265.7	141.1	114.3	11.9
Long-term debt	34.1		96.4	75.8
Other liabilities	183.7	192.6	113.0	92.5	94.9	100.6	117.8	0.1
Total liabilities	342.5	449.1	396.5	376.4	360.6	241.7	232.1	11.9

Shareholders' equity [+]	9.3	76.5	247.6	394.8	635.9	122.6	68.1	131.0
Paid-in capital	1,562.2	1,536.8	1,425.1	1,188.8	1,150.6	493.8	365.3	292.8
Retained earnings	-1,552.9	-1,460.4	-1,177.5	-794.1	-514.4	-370.8	-297.1	-161.4
Treasury stock								-0.2
Tangible shareholders' equity	-45.7	21.4	192.6	339.7	580.9	122.6	68.1	131.0